Invasive aspergillosis among heart transplant recipients: A 24-year perspective

Journal of Heart and Lung Transplantation

Volumn 33, Issue 3, 2014, Pages 278-288

  Muñoz, Patricia ^a,b,c,d   Cerón, Ines ^a,b   Valerio, Maricela ^a,b   Palomo, Jesús ^a   Villa, Adolfo ^a   Eworo, Alia ^a,b   Fernández Yáñez, Juan ^a   Guinea, Jesús ^a,b,c,d   Bouza, Emilio ^a,b,c,d  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Red Española Para la Investigación en Patología Infecciosa RD06 0008 1025   (Spain)

Author keywords

anti fungal prophylaxis; Aspergillus spp; heart transplantation; invasive aspergillosis

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; AZATHIOPRINE; CASPOFUNGIN; CYCLOSPORIN; ITRACONAZOLE; THYMOCYTE ANTIBODY; VORICONAZOLE;

ADULT; AGED; ASPERGILLUS FUMIGATUS; CENTRAL NERVOUS SYSTEM INFECTION; COHORT ANALYSIS; CYTOMEGALOVIRUS INFECTION; DESCRIPTIVE RESEARCH; ENVIRONMENTAL MANAGEMENT; FEMALE; GRAFT RECIPIENT; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; INVASIVE ASPERGILLOSIS; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; MIDDLE AGED; MONOTHERAPY; MORTALITY; PRIORITY JOURNAL; PROSTATITIS; REVIEW;

ANTI-FUNGAL PROPHYLAXIS; ASPERGILLUS SPP; HEART TRANSPLANTATION; INVASIVE ASPERGILLOSIS;

ADULT; AGED; ANTIFUNGAL AGENTS; COHORT STUDIES; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84894301583     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2013.11.003     Document Type: Article

References (49)

1. P. Muñoz, L. Alcala, and M. Sanchez Conde et al. The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis Transplantation 75 2003 326 329
2. P. Grossi, R. De Maria, and A. Caroli et al. Infections in heart transplant recipients: the experience of the Italian heart transplantation program J Heart Lung Transplant 11 1992 847 866
3. P. Grossi, C. Farina, and R. Fiocchi et al. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study Transplantation 70 2000 112 116
4. J.M. Hofflin, I. Potasman, and J.C. Baldwin et al. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids Ann Intern Med 106 1987 209 216
5. M. Hummel, U. Thalmann, and G. Jautzke et al. Fungal infections following heart transplantation Mycoses 35 1992 23 34
6. J.G. Montoya, S.V. Chaparro, and D. Celis et al. Invasive aspergillosis in the setting of cardiac transplantation Clin Infect Dis 37 suppl 3 2003 S281 S292
7. P. Muñoz, C. Rodriguez, and E. Bouza et al. Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis Am J Transplant 4 2004 636 643
8. N. Singh, and D.L. Paterson Aspergillus infections in transplant recipients Clin Microbiol Rev 18 2005 44 69
9. C.V. Paya Fungal infections in solid-organ transplantation Clin Infect Dis 16 1993 677 688
10. R. Guillemain, V. Lavarde, and C. Amrein et al. Invasive aspergillosis after transplantation Transplant Proc 27 1995 1307 1309
11. P. Muñoz, J. Torre, and E. Bouza et al. A large multicentric study invasive aspergillosis in transplant recipients 36th Conference on Antimicrobial Agents and Chemotherapy (New Orleans) 1996 American Society for Microbiology Washington, DC
12. P. Muñoz, J. Palomo, and P. Guembe et al. Lung nodular lesions in heart transplant recipients J Heart Lung Transplant 19 2000 660 667
13. P. Muñoz, J. Palomo, and R. Muñoz et al. Tuberculosis in heart transplant recipients Clin Infect Dis 21 1995 398 402
14. P. Muñoz, M. Valerio, and J. Palomo et al. Targeted antifungal prophylaxis in heart transplant recipients Transplantation 96 2013 664 669
15. Muñoz P, Valerio M, Giannella M, et al. Optimal duration of selective antifungal prophylaxis in heart transplant recipients. In: 21st European Congress of Clinical Microbiology and Infectious Diseases, Milan, Italy; 2010.
16. B. De Pauw, T.J. Walsh, and J.P. Donnelly et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Clin Infect Dis 46 2008 1813 1821
17. J. Loeffler, N. Henke, and H. Hebart et al. Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system J Clin Microbiol 38 2000 586 590
18. P. Ljungman, P. Griffiths, and C. Paya Definitions of cytomegalovirus infection and disease in transplant recipients Clin Infect Dis 34 2002 1094 1097
19. J. Gavalda, O. Len, and R. San Juan et al. Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study Clin Infect Dis 41 2005 52 59
20. P.G. Pappas, B.D. Alexander, and D.R. Andes et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET) Clin Infect Dis 50 2010 1101 1111
21. R.K. Shields, M.H. Nguyen, and M.A. Shullo et al. Invasive aspergillosis among heart transplant recipients is rare but causes rapid death due to septic shock and multiple organ dysfunction syndrome Scand J Infect Dis 44 2012 982 986
22. M. Valerio, A. Fernandez-Cruz, and J. Fernandez-Yanez et al. Prostatic aspergillosis in a heart transplant recipient: case report and review J Heart Lung Transplant 28 2009 638 646
23. J. Guinea, D. Garcia de Viedma, and T. Pelaez et al. Molecular epidemiology of Aspergillus fumigatus: an in-depth genotypic analysis of isolates involved in an outbreak of invasive aspergillosis J Clin Microbiol 49 2011 3498 3503
24. T. Pelaez, P. Muñoz, and J. Guinea et al. Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit Clin Infect Dis 54 2012 e24 e31
25. A. Bergeron, R. Porcher, and A. Sulahian et al. The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies Blood 119 2012 1831 1837
26. T. Franquet, N.L. Muller, and A. Gimenez et al. Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings Radiographics 21 2001 825 837
27. S.Y. Park, S.H. Kim, and S.H. Choi et al. Clinical and radiological features of invasive pulmonary aspergillosis in transplant recipients and neutropenic patients Transpl Infect Dis 12 2010 309 315
28. J. Maertens, J. Verhaegen, and K. Lagrou et al. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation Blood 97 2001 1604 1610
29. J. Maertens, J. Verhaegen, and H. Demuynck et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis J Clin Microbiol 37 1999 3223 3228
30. A. Ulusakarya, E. Chachaty, and J.M. Vantelon et al. Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies Hematol J 1 2000 111 116
31. S. Husain, E.J. Kwak, and A. Obman et al. Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients Am J Transplant 4 2004 796 802
32. E.J. Kwak, S. Husain, and A. Obman et al. Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients J Clin Microbiol 42 2004 435 438
33. J. Fortun, P. Martin-Davila, and M.E. Alvarez et al. Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients Transplantation 71 2001 145 149
34. C.D. Pfeiffer, J.P. Fine, and N. Safdar Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis Clin Infect Dis 42 2006 1417 1427
35. M. Kawazu, Y. Kanda, and Y. Nannya et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1→3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders J Clin Microbiol 42 2004 2733 2741
36. C. Costa, J.M. Costa, and C. Desterke et al. Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis J Clin Microbiol 40 2002 2224 2227
37. J. Loeffler, K. Kloepfer, and H. Hebart et al. Polymerase chain reaction detection of Aspergillus DNA in experimental models of invasive aspergillosis J Infect Dis 185 2002 1203 1206
38. I. Raad, H. Hanna, and D. Sumoza et al. Polymerase chain reaction on blood for the diagnosis of invasive pulmonary aspergillosis in cancer patients Cancer 94 2002 1032 1036
39. C. Mengoli, M. Cruciani, and R.A. Barnes et al. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis Lancet Infect Dis 9 2009 89 96
40. B. Musher, D. Fredricks, and W. Leisenring et al. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid J Clin Microbiol 42 2004 5517 5522
41. M.L. Luong, C.J. Clancy, and A. Vadnerkar et al. Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients Clin Infect Dis 52 2011 1218 1226
42. J. Guinea, C. Padilla, and P. Escribano et al. Evaluation of MycAssay Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer PLoS One 8 2013 e61545
43. T.J. Walsh, E.J. Anaissie, and D.W. Denning et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America Clin Infect Dis 46 2008 327 360
44. N. Singh, and K.J. Pursell Combination therapeutic approaches for the management of invasive aspergillosis in organ transplant recipients Mycoses 51 2008 99 108
45. N. Singh, A.P. Limaye, and G. Forrest et al. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study Transplantation 81 2006 320 326
46. J. Segovia, J.L. Rodriguez-Lambert, and M.G. Crespo-Leiro et al. A randomized multicenter comparison of basiliximab and muromonab (OKT3) in heart transplantation: SIMCOR study Transplantation 81 2006 1542 1548
47. J. Lindenfeld, G.G. Miller, and S.F. Shakar et al. Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs Circulation 110 2004 3734 3740
48. J. Lindenfeld, G.G. Miller, and S.F. Shakar et al. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs Circulation 110 2004 3858 3865
49. M. Rosenhagen, R. Feldhues, and J. Schmidt et al. A risk profile for invasive aspergillosis in liver transplant recipients Infection 37 2009 313 319